摘要
目的:对肝硬化疾病诊断中的生化检验项目的价值进行研究。方法:选择2011年5月-2012年5月笔者所在医院肝硬化诊断患者70例作为观察组,另选择70例身体健康者作为对照组进行对比研究。采用生化分析仪对70例肝硬化患者及70例健康者的血清8项新指标、12项肝功项目及2项血脂项目进行检测,并对检测的结果进行统计学分析。结果:70例肝硬化患者与健康人相比,在天冬氨酸氨基转移酶、谷氨酸脱氢酶、N-乙酰-β-D氨基葡萄糖苷酶、亮氨酸氨基肽酶、α-岩藻糖苷酶及腺苷脱氨酶的检测结果上明显要高,而前白蛋白有所降低。结论:天冬氨酸氨基转移酶、谷氨酸脱氢酶、N-乙酰-β-D氨基葡萄糖苷酶、亮氨酸氨基肽酶、α-岩藻糖苷酶及腺苷脱氨酶指标在肝硬化疾病的诊断中具有较高的检验价值。
Objective： To study the value of liver biochemical tests in diagnosis of cirrhosis disease.Method： Selected 70 cases of cirrhosis disease in our hospital were set as the observation group, the other 70 cases of health person as the control group.Using automatic biochemical analyzer for serum analysis of all the people, contains 8 new indicators, 12 liver projects and 2 lipid projects, and the test results were statistically analyzed.Result： 70 cases of cirrhosis disease compared with 70 cases of health person, the test results of ASTm, GLDH, NAG, LAP, AFU and ADA were significantly higher, and the PAB decreased. Conclusion： The biochemical indicators of ASTm, GLDH, NAG, LAP, AFU and ADA in the diagnosis of cirrhosis disease have high test value.
出处
《中外医学研究》
2013年第36期10-11,共2页
CHINESE AND FOREIGN MEDICAL RESEARCH
